Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 02, 2018 08:30 ET | Source: Arbutus Biopharma Corporation

Arbutus to Present at Chardan’s Genetic Medicines Conference

WARMINSTER, Pa., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr....
October 02, 2018 07:00 ET | Source: ProQR Therapeutics N.V.

ProQR to Present at the Chardan Genetic Medicines Conference

LEIDEN, the Netherlands, Oct. 02, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the...
October 01, 2018 17:15 ET | Source: NewLink Genetics Corporation

NewLink Genetics Announces Indoximod Biomarker Data and Prodrug NLG802 Pharmacokinetic Data to be Presented at SITC 2018

AMES, Iowa, Oct. 01, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that two abstracts were accepted for presentation at the Society for Immunotherapy of Cancer...
September 27, 2018 05:00 ET | Source: HealthLynked Corp

HealthLynked Corp. Announces the Release of its Redesigned Website

NAPLES, Fla., Sept. 27, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK), which connects doctors, patients and data to improve healthcare, announced today the launch of its newly revamped...
September 26, 2018 12:41 ET | Source: Myriad Genetics, Inc.

Myriad Announces New GeneSight® Study Published in Personalized Medicine

SALT LAKE CITY, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a worldwide leader in personalized medicine, today announced that a health economic study to evaluate the...
September 26, 2018 08:30 ET | Source: True Nature Holding, Inc.

True Nature Holding Inc. Appoints Advertising and Digital Web Technology Executives to Advisory Board

ATLANTA, Sept. 26, 2018 (GLOBE NEWSWIRE) -- True Nature Holding, Inc. (OTCQB:TNTY) (the "Company" or "True Nature") announces the appointment of Mr. Jim Crone and Mr. Craig Olivas to its Advisory...
September 26, 2018 08:00 ET | Source: Fibrocell Science Inc.

Fibrocell to Present at Upcoming Industry and Investor Conferences

EXTON, Pa., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc., (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective...
September 25, 2018 17:37 ET | Source: Globus Medical

Globus Medical Sponsors NASS 2018, Hosts In-Booth Presentations on ExcelsiusGPS®

AUDUBON, Pa., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will feature its ExcelsiusGPS® revolutionary robotic guidance and...
September 25, 2018 11:29 ET | Source: Myriad Genetics, Inc.

Myriad Announces Publication of Variant Reclassification Study in the Journal of the American Medical Association

SALT LAKE CITY, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a worldwide leader in personalized medicine, today announced that results from a landmark study of variant...
September 25, 2018 08:00 ET | Source: Fibrocell Science Inc.

Fibrocell Awarded $1.4 Million FDA Orphan Grant for FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa

EXTON, Pa., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective...